[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $ucbjy $UCBJY sees positive social sentiment due to positive clinical trial data and mentions of related assets. Market volatility remains a concern, but positive news is driving engagement. ### About $ucbjy A cryptocurrency. ### Engagements: XX [#](/topic/$ucbjy/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$ucbjy/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXXXX -XX% **1 Month**: XXXXX -XX% **1-Year High**: XXXXX on 2025-04-29 **1-Year Low**: X on 2025-05-10 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$ucbjy/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$ucbjy/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X -XX% **1-Year High**: X on 2025-09-04 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$ucbjy/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$ucbjy/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $ucbjy in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X no change **1-Year High**: X on 2025-04-29 **1-Year Low**: X on 2025-04-27 The most influential creators that mention $ucbjy in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Quantumup1](/creator/twitter/Quantumup1) | X | XXXXX | X | XX | [View More](/list/creators/$ucbjy/100) ### Sentiment: % [#](/topic/$ucbjy/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$ucbjy/time-series/sentiment.tsv) **Current Value**: % **Daily Average**: XXX% **1 Month**: XXX% no change **1-Year High**: XXX% on 2025-04-30 **1-Year Low**: XXX% on 2025-04-30 **Top assets mentioned** In the posts about $ucbjy in the last XX hours [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan) [Biogen Inc (BIIB)](/topic/biogen-inc) [Biogen Inc (BIIB)](/topic/$biib) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) **Top topics mentioned** In the posts about $ucbjy in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$imvt](/topic/$imvt), [$roiv](/topic/$roiv), [johnson johnson](/topic/johnson-johnson), [$argx](/topic/$argx), [stocks industrials](/topic/stocks-industrials), [stocks energy](/topic/stocks-energy), [$elan](/topic/$elan), [coins defi](/topic/coins-defi), [$stok](/topic/$stok), [biogen inc](/topic/biogen-inc), [$biib](/topic/$biib), [$jazz](/topic/$jazz) ### Top Social Posts [#](/topic/$ucbjy/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Stocks she sold: Healthcare & Pharma: $UNH $LLY $MRK $GILD $JNJ $CVS $CI $AZN $GSK $HLN $ELAN $UCBJY $TMO $MCK Industrials Energy & Materials: $XOM $CVX $COP $SHEL $DE $CAT $ETN $EMR $TT $URI $TOL $FDX $UPS $GE $GEV $BA $NSC $UNP $WAB $TDG $MLM $CRH $MOS $NEM $NTR $IMO $CNQ $FQVLF" [X Link](https://x.com/GovStockTracker/status/1976636000928440468) [@GovStockTracker](/creator/x/GovStockTracker) 2025-10-10T13:08Z 9644 followers, XXX engagements "Needhamthe PT on $STOK to $XX from $XX and reiterated at a Buy rating after STOK presented new zorevuneren OLE data in Dravet Syndrome (DS) at the 54th Child Neurology Society (CNS) annual meeting yesterday. $BIIB $JAZZ UCBJY UCBJF Needham said in its note: The new data showed 1) patients treated with zorevunersen had continued improvements in clinical outcomes through X years and 2) an analysis of patients in the OLE who received a similar dosing regimen as the ongoing Ph3 trial continued to show improvements in the Vineland-3 (cognition & behavior) at X years vs. a DS natural history study." [X Link](https://x.com/Quantumup1/status/1976615201718903033) [@Quantumup1](/creator/x/Quantumup1) 2025-10-10T11:46Z 3846 followers, 1793 engagements "Oppenheimer reiterated $IMVT Outperform/$54. $ROIV $ARGX $JNJ $VRDN $AMGN $RHHBY $TAK $TRML Oppenheimer said: $IMVT announced inspiring remission data in uncontrolled Graves' patients that showed a high rate of durable responses off batoclimab which the company detailed in a call w/slides. About XX% (17/21) of patients followed after the positive Phase 2's treatment portion maintained normal thyroid hormone levels six months off bato of whom half (8/17) achieved remission without anti-thyroid drugs. These results not only underscore FcRn inhibition as a means to address the 25-30% of Graves'" [X Link](https://x.com/Quantumup1/status/1963651815343628456) [@Quantumup1](/creator/x/Quantumup1) 2025-09-04T17:14Z 3845 followers, 2918 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$UCBJY sees positive social sentiment due to positive clinical trial data and mentions of related assets. Market volatility remains a concern, but positive news is driving engagement.
A cryptocurrency.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXXXX -XX%
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-04-29
1-Year Low: X on 2025-05-10
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-09-04
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $ucbjy in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X no change
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-04-27
The most influential creators that mention $ucbjy in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@Quantumup1 | X | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XXX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-04-30
1-Year Low: XXX% on 2025-04-30
Top assets mentioned In the posts about $ucbjy in the last XX hours
Immunovant, Inc. Common Stock (IMVT) Roivant Sciences Ltd. Common Shares (ROIV) Johnson & Johnson (JNJ) Elanco Animal Health Incorporated Common Stock (ELAN) Biogen Inc (BIIB) Biogen Inc (BIIB) Jazz Pharmaceuticals, Inc. (JAZZ)
Top topics mentioned In the posts about $ucbjy in the last XX hours
stocks healthcare, $imvt, $roiv, johnson johnson, $argx, stocks industrials, stocks energy, $elan, coins defi, $stok, biogen inc, $biib, $jazz
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Stocks she sold: Healthcare & Pharma: $UNH $LLY $MRK $GILD $JNJ $CVS $CI $AZN $GSK $HLN $ELAN $UCBJY $TMO $MCK Industrials Energy & Materials: $XOM $CVX $COP $SHEL $DE $CAT $ETN $EMR $TT $URI $TOL $FDX $UPS $GE $GEV $BA $NSC $UNP $WAB $TDG $MLM $CRH $MOS $NEM $NTR $IMO $CNQ $FQVLF"
X Link @GovStockTracker 2025-10-10T13:08Z 9644 followers, XXX engagements
"Needhamthe PT on $STOK to $XX from $XX and reiterated at a Buy rating after STOK presented new zorevuneren OLE data in Dravet Syndrome (DS) at the 54th Child Neurology Society (CNS) annual meeting yesterday. $BIIB $JAZZ UCBJY UCBJF Needham said in its note: The new data showed 1) patients treated with zorevunersen had continued improvements in clinical outcomes through X years and 2) an analysis of patients in the OLE who received a similar dosing regimen as the ongoing Ph3 trial continued to show improvements in the Vineland-3 (cognition & behavior) at X years vs. a DS natural history study."
X Link @Quantumup1 2025-10-10T11:46Z 3846 followers, 1793 engagements
"Oppenheimer reiterated $IMVT Outperform/$54. $ROIV $ARGX $JNJ $VRDN $AMGN $RHHBY $TAK $TRML Oppenheimer said: $IMVT announced inspiring remission data in uncontrolled Graves' patients that showed a high rate of durable responses off batoclimab which the company detailed in a call w/slides. About XX% (17/21) of patients followed after the positive Phase 2's treatment portion maintained normal thyroid hormone levels six months off bato of whom half (8/17) achieved remission without anti-thyroid drugs. These results not only underscore FcRn inhibition as a means to address the 25-30% of Graves'"
X Link @Quantumup1 2025-09-04T17:14Z 3845 followers, 2918 engagements
/topic/$ucbjy